# "All Comers" Post Market Clinical Follow-up (PMCF) With Multi-LOC for flOw liMiting Outcomes

> **NCT02531230** · — · COMPLETED · sponsor: **B. Braun Melsungen AG** · enrollment: 75 (actual)

## Conditions studied

- Peripheral Arterial Occlusive Disease

## Interventions

- **DEVICE:** VascuFlex Multi-LOC®

## Key facts

- **NCT ID:** NCT02531230
- **Lead sponsor:** B. Braun Melsungen AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2016-07
- **Final completion:** 2017-08
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2018-10-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02531230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02531230, ""All Comers" Post Market Clinical Follow-up (PMCF) With Multi-LOC for flOw liMiting Outcomes". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02531230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*